Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 28, 2013; 19(12): 1861-1876
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1861
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1861
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy
John L Wallace, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4K1, Canada
John L Wallace, Inflammation Research Network, University of Calgary, Calgary, AB T2N 4N1, Canada
Author contributions: Wallace JL solely contributed to this paper.
Supported by A grant from the Canadian Institutes of Health Research
Correspondence to: John L Wallace, PhD, MBA, FRSC, Farncombe Family Digestive Health Research Institute, McMaster University, 1280 Main Street West, HSC-3N4, Hamilton, ON L8S 4K1, Canada. altapharm@hotmail.com
Telephone: +1-905-5156132 Fax: +1-905-5289862
Received: January 23, 2013
Revised: March 6, 2013
Accepted: March 7, 2013
Published online: March 28, 2013
Revised: March 6, 2013
Accepted: March 7, 2013
Published online: March 28, 2013
Core Tip